KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups
September 24, 2026
September 24, 2026
MEMPHIS, Tennessee, Sept. 24 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups
*
Targeting KDM2B, or downstream protein complexes it recruits, may present a vulnerability in high-risk medulloblastoma subgroups that currently lack targeted therapies. This finding comes from a study led by St. Jude Children& . . .
* * *
KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups
*
Targeting KDM2B, or downstream protein complexes it recruits, may present a vulnerability in high-risk medulloblastoma subgroups that currently lack targeted therapies. This finding comes from a study led by St. Jude Children& . . .